Upadacitinib 00074-2241-99
- Manufacturer
- Abbvie Inc.
- Dosage Form
- Tablet
- Product Type
- Drug For Further Processing
- Marketing Start
- June 14, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Upadacitinib | 45 mg/1 |
Selected Package
00074-2241-99Selected30428 TABLET in 1 DRUM (0074-2241-99)